Clinical trial · Interventional
Outpatient Neutropenic Diet Study
Are Neutropenic Diets Beneficial to Improve Outcome?
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Slow Accrual
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the infection rate of leukemia patients who eat two different diets. Patients in the "raw" group will eat cooked food and the addition of raw fruits and vegetables. Patients in the "cooked" group will eat only cooked foods and this is the standard neutropenic diet with no fresh fruits or vegetables allowed. The primary objective of the study is to evaluate the infection rate of leukemia patients who eat two different diets. The secondary objectives will be the incidence of fever requiring intravenous antibiotics in each group and death rate.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Leukemia | Leukemia | ONTOLOGY_EXACT | 0.90 |
| Neutropenia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cooked Foods | Other | — | UNRESOLVED |
| Raw Fruits & Vegetables | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- "Raw" Group
- description
- Participants will eat cooked food and the addition of raw fruits and vegetables.
- interventionNames
- Other: Raw Fruits & Vegetables
- type
- OTHER
- label
- "Cooked" Group
- description
- Participants will eat only cooked foods.
- interventionNames
- Other: Cooked Foods
Primary outcomes (2)
- measure
- Number of Bactermia in Each Participant Group
- timeFrame
- 6 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy. 2. Patients who will be receiving myelosuppressive chemotherapy for their disease. 3. Patients who will be able to stay in the Houston area for at least 4 weeks. 4. Patients who can speak either English or Spanish. Exclusion Criteria: 1. Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection. 2. Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish. 3. Patients who are admitted to the protective environment. 4. Patients who are younger than age 18 will not be entered in the study. 5. Pregnant patients.
References
Publications (0)
Data not yet available